Cargando…
Teprotumumab for Treatment of Pretibial Myxedema
Pretibial myxedema (PTM), also called thyroid dermopathy, is a dreaded and potentially debilitating manifestation of thyroid disease, more commonly Graves' disease, which can occur at any time over the course of the disease. No substantial long-term therapies have been able to target the condit...
Autores principales: | Reyes, Michelangelo P, Cabrera, John, Singh, Jasvir, Turnbull, Dennis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578414/ https://www.ncbi.nlm.nih.gov/pubmed/37908268 http://dx.doi.org/10.1210/jcemcr/luac037 |
Ejemplares similares
-
A case of pretibial myxedema treated with teprotumumab
por: Petit, Lauren, et al.
Publicado: (2021) -
Resolution of pretibial myxedema with teprotumumab in a patient with Graves disease
por: Varma, Aakaash, et al.
Publicado: (2020) -
Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab
por: Bowens, Brendan K., et al.
Publicado: (2022) -
FRI554 Pretibial Myxedema Associated With Hashimoto Thyroiditis Treated With Teprotumumab
por: Marta Niedzialkowska, Ewelina, et al.
Publicado: (2023) -
Pretibial Myxedema Presenting as Severe Elephantiasis
por: Lee, Jae-Hoon, et al.
Publicado: (2018)